Relationship between promoter methylation of p16, DAPK and RARβ genes and the clinical data of non-small cell lung cancer

Chinese Journal of Medical Genetics

Volumn 28, Issue 1, 2011, Pages 23-28

  Zhang, Chen Ye ^a   Jin, Yong Tang ^a   Xu, He Yun ^b   Zhang, Hu ^b   Zhang, Wei Min ^b   Sun, Xiao Yu ^a   Tan, Cong ^a   Chen, Chun Mei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

DAPK gene; Methylation; Non small cell lung cancer; p16 gene; RAR gene

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P16; RETINOIC ACID RECEPTOR BETA;

ARTICLE; ASSOCIATION; CANCER STAGING; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DAPK GENE; DNA METHYLATION; GENE INTERACTION; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; P16 GENE; PRIMARY TUMOR; PROMOTER REGION; RETINOIC ACID RECEPTOR BETA GENE; RISK FACTOR;

APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; GENES, P16; LOGISTIC MODELS; LUNG NEOPLASMS; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; SMOKING;

NICOTIANA TABACUM;

EID: 79952398109     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2011.01.006     Document Type: Article

References (22)

1. Dammann R, Strunnikova M, Schagdarsurengin U, et al. CpG island methylation and expression of tumour-associated gene in lung carcinoma. Eur J Cancer, 2005, 41:1223-1236. (Pubitemid 40725582)
2. Wang Y, Zhang D, Zheng W, et al. Multiple gene methylation of non small cell lung cancers evaluated with 3-dimensional microarray. Cancer, 2008, 112:1325-1336. (Pubitemid 351429748)
3. Feng Q, Hawes SE, Stern JE, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev, 2008, 17:645-654. (Pubitemid 351469215)
4. Zochbauer-Muller S, Fong KM, Virmani AK, et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res, 2001, 61:249-255. (Pubitemid 32095725)
5. Yanagawa N, Tamura G, Oizumi H, et al. Promoter hypermethylation of RASSFIA and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer, 2007, 58:131-138. (Pubitemid 47379969)
6. Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer, 2003, 103:153-160. (Pubitemid 35461506)
7. Gilbert SF. Ageing and cancer as diseases of epigenesis. J Biosci, 2009, 34:601-604.
8. Nishida N, Nagasaka T, Nishimura T, et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology, 2008, 47:908-918. (Pubitemid 351449682)
9. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer, 2004, 4:988-993.
10. Kirsch-Volders M, Bonassi S, Herceg Z, et al. Gender-related differences in response to mutagens and carcinogens. Mutagenesis, 2010, 25:213-221.
11. Gu J, Berman D, Lu C, et al. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res, 2006, 12:7329-7338. (Pubitemid 46095405)
12. Buckingham L, Penfield-Faber L, Kim A, et al. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II non-small cell lung cancer patients. Int J Cancer, 2010, 126:1630-1639.
13. Liu Y, Gao W, Siegfried JM, et al. Promoter methylation of RASSFlA and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer, 2007, 7:74.
14. Georgiou E, Valeri R, Tzimagiorgis G, et al. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking. Eur J Cancer Prev, 2007, 16:396-402. (Pubitemid 47549998)
15. Vaissiere T, Hung RJ, Zaridze D, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res, 2009, 69:243-252.
16. Baryshnikova E, Destro A, Infante MV, et al. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res, 2008, 14:1913-1919. (Pubitemid 351469479)
17. Cui X, Wakai T, Shirai Y, et al. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci, 2006, 91:372-381. (Pubitemid 43827290)
18. Kondo K, Takahashi Y, Hirose Y, et al. The reduced expression and aberrant methylation of p16 (ink4a) in Chromate workers with lung cancer. Lung Cancer, 2006, 53:295-302. (Pubitemid 44192596)
19. Govindarajan B, Klafter R, Miller MS, et al. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16 (Ink4a) and activation of MAP kinase. Mol Med, 2002, 8:1-8. (Pubitemid 34451115)
20. Kowara R, Salnikow K, Diwan BA, et al. Reduced Fhit protein expression in nickel transformed mouse cells and in nickel-induced murine sarcomas. Mol Cell Biochem, 2004, 255:195-202.
21. Lin RK, Hsieh YS, Lin P, et al. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest, 2010, 120:521-532.
22. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer, 2008, 123:1-7. (Pubitemid 351705185)